Literature DB >> 22108506

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.

Olivier George1, Michel Le Moal, George F Koob.   

Abstract

Allostasis, originally conceptualized to explain persistent morbidity of arousal and autonomic function, is defined as the process of achieving stability through physiological or behavioral change. Two types of biological processes have been proposed to describe the mechanisms underlying allostasis in drug addiction, a within-system adaptation and a between-system adaptation. In the within-system process, the drug elicits an opposing, neutralizing reaction within the same system in which the drug elicits its primary and unconditioned reinforcing actions, while in the between-system process, different neurobiological systems that the one initially activated by the drug are recruited. In this review, we will focus our interest on alterations in the dopaminergic and corticotropin releasing factor systems as within-system and between-system neuroadaptations respectively, that underlie the opponent process to drugs of abuse. We hypothesize that repeated compromised activity in the dopaminergic system and sustained activation of the CRF-CRF1R system with withdrawal episodes may lead to an allostatic load contributing significantly to the transition to drug addiction. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108506      PMCID: PMC3288230          DOI: 10.1016/j.physbeh.2011.11.004

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  102 in total

1.  Axon terminals containing tyrosine hydroxylase- and dopamine-beta-hydroxylase immunoreactivity form synapses with galanin immunoreactive neurons in the lateral division of the bed nucleus of the stria terminalis in the rat.

Authors:  T Kozicz
Journal:  Brain Res       Date:  2001-09-28       Impact factor: 3.252

2.  Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats.

Authors:  N E Goeders; G F Guerin
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

Review 3.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

4.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

5.  PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.

Authors:  Michael A Nader; Drake Morgan; H Donald Gage; Susan H Nader; Tonya L Calhoun; Nancy Buchheimer; Richard Ehrenkaufer; Robert H Mach
Journal:  Nat Neurosci       Date:  2006-07-09       Impact factor: 24.884

6.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

7.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

8.  Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons.

Authors:  Alice Dobi; Elyssa B Margolis; Hui-Ling Wang; Brandon K Harvey; Marisela Morales
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

9.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

10.  Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.

Authors:  G Schulteis; A Markou; L H Gold; L Stinus; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

View more
  70 in total

1.  Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse.

Authors:  Thibaut Sesia; Anthony A Grace
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-03       Impact factor: 11.205

Review 2.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

3.  Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.

Authors:  Rodrigo M Leão; Fábio C Cruz; Leandro F Vendruscolo; Giordano de Guglielmo; Marian L Logrip; Cleopatra S Planeta; Bruce T Hope; George F Koob; Olivier George
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 4.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

5.  Synaptic Plasticity in the Bed Nucleus of the Stria Terminalis: Underlying Mechanisms and Potential Ramifications for Reinstatement of Drug- and Alcohol-Seeking Behaviors.

Authors:  Nicholas A Harris; Danny G Winder
Journal:  ACS Chem Neurosci       Date:  2018-06-13       Impact factor: 4.418

Review 6.  Interventions to address parenting and parental substance abuse: conceptual and methodological considerations.

Authors:  Emily N Neger; Ronald J Prinz
Journal:  Clin Psychol Rev       Date:  2015-04-24

7.  Effects of adolescent alcohol exposure on stress-induced reward deficits, brain CRF, monoamines and glutamate in adult rats.

Authors:  Nathalie Boutros; Andre Der-Avakian; James P Kesby; Soon Lee; Athina Markou; Svetlana Semenova
Journal:  Psychopharmacology (Berl)       Date:  2017-11-27       Impact factor: 4.530

Review 8.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

9.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

Review 10.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.